Director, New Products Value and Evidence

Responsibilities

• Ensure that real-world evidence and market access scientific requirements are identified early and integrated into U.S. development and business plans.
• Develop evidence to support differentiated value propositions reflecting the needs of payer and other access stakeholders, and lead NPV&E strategic planning to support development decisions, launch readiness, and sustained access.
• Lead NPV&E strategy and execution, including formulating priority research questions; identifying analytical needs that inform market access and development strategy; designing and conducting studies and market access analytics; managing publications; developing evidence and access communication materials; and partnering with V&ESE Field to enable effective, compliant scientific exchange with payer and other access stakeholders.
• Ensure that NPV&E priorities are integrated into the Integrated Evidence Generation Plan (IEGP), aligned with business, payer, policy, and patient evidence needs, and executed with appropriate quality and timeliness.
• Engage internal and external experts to refine evidence priorities and strengthen the scientific rigor and relevance of evidence-generation and dissemination plans.
• Ensures compliance with regulatory, legal and commercial regulations (for example Contract Pricing Committee, Copy Approval Committee) in conducting research and dissemination of scientific information.
• Assess the potential implications of the Inflation Reduction Act (IRA) and other evolving U.S. policy and reimbursement changes for pipeline assets, and translate those implications into early evidence priorities, development decisions, and lifecycle evidence needs, as appropriate.
• Partner with cross-functional stakeholders to translate market access evidence needs into actionable scientific strategies and development recommendations for assigned products.
• Initiate and manage selected research studies and related projects, including scope, timelines, resources, vendor oversight, and delivery of decision-relevant outputs.
• Serve as the NPV&E subject-matter and functional expert for U.S.-focused health technology assessments, value assessments, and other external evidence reviews of assigned products, coordinating cross-functional responses and evidence strategies as appropriate.
• Establish and maintain quality standards for the design, execution, interpretation, and publication of real-world evidence studies and for models and tools developed for business partners.
• Develop annual business plan budget, present to appropriate levels of management for approval, and manage budgeted funds appropriately.
• Ensure quality in internal / external communications including: publications, training support of RWVE studies, and models and/or tools developed to support the product.

Qualifications

Education: A minimum of a Master's degree in Public Health, Health Services Research, Economics, Epidemiology, Pharmacy, Health Policy, or a related discipline is required; a doctorate or other advanced degree is preferred.

Experience and skills: Required: A minimum of 7 or more years of relevant research experience. Expertise in healthcare industry, clinical knowledge or practice across multiple therapeutic areas, medical reimbursement, technical expertise in economic evaluations or patient reported outcomes, including data analysis and statistics. Demonstrated leadership, collaboration, influencing, and communication skills, including the ability to translate complex scientific and technical information into clear, decision-relevant insights for diverse audiences. Serve as a leader on the assigned cross-functional franchise teams pertaining to observational data or research, market access scientific strategy, payer insights/ data needs, etc. Experience in communicating technical data both internally and externally to non-technical audiences. Independent high-level planning and execution of research strategies. Solid experience in conducting Real World Evidence studies applying health economics, patient-reported outcomes, retrospective data analyses, epidemiology or health services research. Firm understanding of drug development process including health economic inputs needed to support the value proposition. Firm understanding of regulatory standards for approval and communication of data. Strong understanding of the U.S. healthcare system, payer and access stakeholders, reimbursement models, health technology and value assessment, and the evolving policy environment that influences evidence expectations and patient access. Firm understanding of the uses of evidence-based medicine and comparative effectiveness analyses for health policy decision-making. Up to 30% travel required mostly national with occasional international travel.

Preferred: Experience in developing and gaining management approval for value-based scientific strategies and tactics to meet both commercial and scientific objectives for a given product or therapeutic area.